Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma
Abstract Oral squamous cell carcinoma (OSCC) remains one of the most challenging clinical problems in the field due to its high rate of locoregional and distant metastases. However, studies that assess the association between aspirin use and survival in patients with OSCC are limited. Moreover, pati...
Main Authors: | Sheng-Dean Luo, Shao-Chun Wu, Wei-Chih Chen, Ching-Nung Wu, Tai-Jan Chiu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Chang-Chun Hsiao, Chang-Han Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96614-y |
Similar Items
-
Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan
by: Sheng-Dean Luo, et al.
Published: (2020-06-01) -
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
by: Ho-Chang Kuo, et al.
Published: (2015-01-01) -
Critical Overview on the Benefits and Harms of Aspirin
by: Chun Shing Kwok, et al.
Published: (2010-05-01) -
The Effects of Aspirin Loading Dose in Acute Ischemic Stroke
by: Tse Hsuan Su, et al.
Published: (2018) -
Effect of different doses of aspirin on the prognosis of Kawasaki disease
by: Jinxin Wang, et al.
Published: (2020-06-01)